Skip to search formSkip to main contentSkip to account menu

HB-419

Known as: HB 419, HB419 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Glyburide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Toxicology of Sulfonylureas
Since 1958, Hoechst AG, Frankfurt, and Boehringer Mannheim GmbH have synthesized and pharmacologically tested a large number of… 
1989
1989
Cyclosporine A + Glybenclamide. Effect on Glucose Metabolism: Preliminary Results
Cyclosporine A (CsA) is an immunosuppressive drug which determines, at high dosage, glucose intolerance (1). Different drugs… 
1987
1987
Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide, HB419 and HB420, in non insulin-dependent (type 2) diabetes.
The pharmacokinetics and pharmacological properties of a new micronized preparation of glibenclamide (HB420, 3.5 mg/tablet) were… 
1983
1983
Effect of a hypoglycaemic sulphonylurea (HB419) and a non-metabolizable amino acid (BCH) on the insulin release and endogenous substrate metabolism of rat pancreatic islets.
The effects of the hypoglycaemia sulphonylurea glibenclamide (HB419) and the non-metabolizable leucine analogue beta-2… 
Highly Cited
1972
Highly Cited
1972
The Stimulus‐Secretion Coupling of Glucose‐Induced Insulin Release VIII. Combined Effects of Glucose and Sulfonylureas *
Abstract. Sulfonylureas such as BS4231 and HB419 stimulate insulin secretion in pieces of rat pancreatic tissue. Their… 
1971
1971
Glibenclamide (HB 419, Daonil) in the clinical practice of diabetes.
Summary 1. Eighty-nine patients were observed for periods up to two years by the same observer in nearly every case. After… 
1971
1971
Study on a new antidiabetic agent, glibenclamide (HB419). A clinical evaluation and comparative study.
1970
1970
[Antidiabetic drugs--application and problems, with special reference to Glibenclamide (HB419)].
1969
1969
[Experimental study of a new especially active hypoglycemic sulfonamide, HB-419 or Glibenclamide].
1969
1969
HB419 (glibenclamide) in the treatment of diabetes mellitus.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)